| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment (NCT04744688) | University of Aarhus | 2021-04-06 |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases (NCT05322486) | State Scientific Centre of Coloproctology, Russian Federation | 2020-10-29 |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
| Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma (NCT03559543) | Catalysis SL | 2018-10-25 |
| Study of Small Bowel Tumor With Dual-phase Enhanced Computed Tomography (CTE) and Magnetic Resonance Enterography (MRE) (NCT03659357) | Tongji Hospital | 2018-09-01 |
| Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) (NCT03271255) | Shenzhen People's Hospital | 2018-05-23 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer (NCT03280407) | Zealand University Hospital | 2017-03-01 |
| BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities (NCT03072472) | South Tyneside and Sunderland NHS Foundation Trust | 2017-02-14 |
| Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection (NCT02785783) | Portsmouth Hospitals NHS Trust | 2016-05-13 |
| Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer (NCT02202928) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2014-07-01 |
| A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (NCT01996306) | Epidemiological and Clinical Research Information Network | 2013-12-02 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC (NCT03303495) | Sun Yat-sen University | 2011-11-14 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |